TABLE 4.

Description of adverse events according to stage

	Total N=114 (%)	Stage II N=5 (%)	Stage III N=61 (%)	Stage IV/B- ALL N=41 (%)	Unknown N=7 (%)
Early death	13 (11)	0	4 (7)	5 (12)	4 (57)
Death in Induction	21 (18)	2 (40)	11 (18)	7 (17)	1 (14)
Relapse	22 (19)	1 (20)	9 (15)	12 (29)	0
Progressive disease	24 (21)	0	10 (16)	14 (34)	0
Death in complete remission	9 (8)	1 (20)	8 (13)	0	0
Abandonment or treatment refusal	23 (20)	1 (20)	18 (30)	2 (5)	2 (29)
Other	2 (2)	0	Second malignancy N=1 (2)	Death of unknown cause N=1 (2)	0